IBIO

iBio, Inc. is an innovative biotechnology company headquartered in New York, specializing in plant-based biopharmaceutical production. The company provides contract development and manufacturing services tailored to the production of biologics, including vaccines and therapeutics, thereby positioning itself as a critical partner for organizations both domestically and globally. Leveraging its proprietary technologies, iBio is committed to advancing the efficiency and scalability of biologics manufacturing, effectively addressing the growing demand for sustainable and cost-effective solutions in the dynamic life sciences industry.